Involvement of hydrogen peroxide in asbestos-induced NFAT activation

Molecular and Cellular Biochemistry

Volumn 234-235, Issue , 2002, Pages 161-168

  Li, Jingxia ^a   Huang, Bihui ^a   Shi, Xianglin ^b   Castranova, Vincent ^b   Vallyathan, Val ^b   Huang, Chuanshu ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH   (United States)

Author keywords

Asbestos; NFAT; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; ASBESTOS; CALCINEURIN; CATALASE; CYCLOSPORIN; CYTOKINE; FORMIC ACID; HYDROGEN PEROXIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATASE; REACTIVE OXYGEN METABOLITE; SODIUM; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT; DNA BINDING PROTEIN; NUCLEAR PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO; EXPOSURE; FIBROBLAST; INCUBATION TIME; MOUSE; NONHUMAN; SCAVENGING SYSTEM; TRANSACTIVATION; ANIMAL; CELL LINE; DRUG EFFECT; METABOLISM; TIME;

ACETYLCYSTEINE; ANIMAL; ASBESTOS; CELL LINE; CYCLOSPORINE; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; MICE; SUPEROXIDE DISMUTASE; SUPPORT, U.S. GOV'T, P.H.S.; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; ANIMALS; NFATC TRANSCRIPTION FACTORS; NUCLEAR PROTEINS;

EID: 4243334765     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1015962916195     Document Type: Article

References (52)

1. Asbestos: Scientific developments and implications for public policy
2. Mechanisms of carcinogenesis and clinical features of asbestos-associated careers
3. Cellular and molecular basis of asbestos-related diseases
4. Asbestosis: Clinical spectrum and pathogenic mechanisms
5. The role of free radicals in asbestos-related diseases
6. The role of oxygen free radicals in occupational and environmental lung diseases
7. Asbestos induces nuclear factor NF-κB DNA binding activity and NF-κB dependent gene expression in tracheal epithelial cells
8. Asbestos induces activator AP-1 trancactivation in transgenic mice
9. Analyzing the genes and peptide growth factors expressed in lung cells in vivo consequent to asbestos exposure and in vitro
10. Cell signaling pathways elicited by asbestos
11. Inhibition of protein kinase C prevents asbestos-induced c-fos abd c-jun proto-oncogenes expression in mesothelial cells
12. Characterization of antigen receptor response elements within the interleukin-2 enhancer
13. Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes
14. Identification of a putative regulator of early T cell activation genes
15. Transcription mediated by NFAT is highly inducible in effector CD4+ T helper 2 (Th2) cells but not in Th1 cells
16. Transcription factors of the NFAT family: Regulation and function
17. Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation
18. Cyclosporin A specifically inhibits function of nuclear proteins involved in T cell activation
19. Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A
20. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun
21. FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin
22. The actions of cyclosporin A and FK506 suggest a novel step in the activation of T lymphocytes
23. Signal transmission between the plasma membrane and nucleus of T lymphocytes
24. Transcriptional regulation of the IL-2 gene
25. The architecture of the interleukin-2 promoter: A reflection of T lymphocyte activation
26. Isolation of the cyclosporin-sensitive T cell transcription factor NFATp
27. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes
28. Isolation of two new members of the NF-AT gene family and functional characterization of the NFAT proteins
29. NFATx, a novel member of the nuclear factor of activated T cells family that is expressed predominantly in the thymus
30. NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity
31. Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc
32. Signaling into the T-cell nucleus: NFAT regulation
33. NF-AT components define a family of transcription factors targeted in T-cell activation
34. Involvement of nuclear factor of activated T cells activation in UV response. Evidence from cell culture and transgenic mice
35. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8
36. Anti-tumor-promoting action of FK506, a potent immunosuppressive agent
37. Vanadium-induced nuclear factor of activated T cells activation through hydrogen peroxide
38. Blocking activator protein-1 activity, but not activating retinoic acid response element, is required for the antitumor promotion effect of retinoic acid
39. Iron in asbestos chemistry and carcinogenicity
40. Enhanced generation of free radicals from phagocytes induced by mineral dusts
41. The uptake of mineral particles by pulmonary epithelial cells
42. Mechanisms of the pathogenesis of asbestos and silicosis
43. Comparison of effects of hydrogen peroxide and x-ray irradiation on toxicity, mutation and DNA damage/repair in mammalian cells
44. Asbestos induces apoptosis of human and rabbit pleural mesothelial cells via reactive oxygen species
45. Activation of extracellular signal regulated kinase, ERK2 by p21 ras oncoprotein
46. Oxidant carcinogenesis and antioxidant defense
47. Partners in transcription: NFAT and AP-1
48. Nuclear factor of activated T cells contains Fos and Jun
49. Role of kinases and the phosphatase calcineurin in the nuclear shuttling of transcription factor NF-AT4
50. Nuclear accumulation of NFAT4 opposed by the JNK signal transduction pathway
51. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB
52. Inhibitors of permeability transition interfere with the disruption of the mitochondrial transmembrane potential during apoptosis